In a leadership shakeup, the diet company says CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

Now, there’s a new type of prescription joining the conversation—and it may lower your chances of getting dementia. A recent study found that a class of medications called SGLT-2 inhibitors—which does ...

Under the new law, the drugs mifepristone and misoprostol will be designated as Schedule IV controlled substances.

"Pharmacy middlemen" are to blame for the high cost of drugs like Wegovy and Ozempic, according to Novo Nordisk's CEO. Is ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

The new weight-loss drugs were originally developed as a treatment for type 2 diabetes. They work by mimicking a gut hormone usually released after eating, called GLP-1. This hormone makes people feel ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

Exploding sales of prescription weight loss medications have catapulted Novo Nordisk (NVO) and Eli Lilly (LLY) to become the ...

In the U.K., a pharma-run watchdog has been issuing fines and levying suspensions. Could this help build public trust?

Amgen's strong dividend growth, with a 2.8% yield and consistent hikes since 2011. Read what makes AMGN stock is a worthy ...